These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7329613)

  • 1. [Effects of different types of substitutive treatment on fibrinolytic potential of chronic uremic patients].
    Canavese C; Stratta P; Mangiarotti G; Triolo G; Bagnis C; Racca M; Vercellone A
    Minerva Nefrol; 1981; 28(3):339-43. PubMed ID: 7329613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Substitutive treatment of the uremic diabetic. 8 years of experience and new prospects].
    Triolo G; Thea A; Carta Q; Stratta P; Vacha GM; Giorda G; Paola M; Segoloni GP; Piccoli G; Vercellone A
    Minerva Nefrol; 1981; 28(3):315-20. PubMed ID: 7329609
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative losses of free amino acids and their plasma variations in artificial substitutive programmes for chronic uraemia.
    Scolari MP; Stefoni S; Mosconi G; Feliciangeli G; Colì L; Bonomini V
    Life Support Syst; 1983; 1(1):51-60. PubMed ID: 6678371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alternative procedures in the therapy of chronic uremia (hemofiltration, continuing ambulatory peritoneal dialysis)].
    Scheler F
    Verh Dtsch Ges Inn Med; 1981; 87():1405-8. PubMed ID: 7331435
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of renal substitutive programs on amino acid patterns in chronic uremia.
    Scolari MP; Stefoni S; Mosconi G; Colì L; Feliciangeli G; Baldrati L; Buscaroli A; Prandini R; Bonomini V
    Kidney Int Suppl; 1983 Dec; 16():S77-80. PubMed ID: 6376922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in platelets, coagulation and fibrinolysis in patients with chronic renal failure].
    Terada H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():147-52. PubMed ID: 15250284
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of chronic uremia by dialysis].
    Lampainen E
    Duodecim; 1983; 99(17):1218-26. PubMed ID: 6357721
    [No Abstract]   [Full Text] [Related]  

  • 9. Forces determining selection of uremia therapy.
    Friedman EA; Lundin AP
    Adv Nephrol Necker Hosp; 1984; 13():151-62. PubMed ID: 6433665
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of hemostasis and coagulation in uremic patients during extra-corporeal dialysis].
    Praga C; Brancaccio D; Cortellaro M; Pisani E; Della Grazia ME
    Minerva Nefrol; 1966; 13(4):122-33. PubMed ID: 5995533
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of ultrafiltration in the treatment of congestive cardiac decompensation in uremic patients].
    Giombini L; Pentiricci N; Coppi V; Coli L
    G Clin Med; 1984; 65(7-8):317-23. PubMed ID: 6500208
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disorders of hemostasis and blood coagulation during uremia. 3. Role of platelet anomalies and action of hemodialysis and renal grafts].
    Moriau M
    Pathol Eur; 1966; 1(1):273-97. PubMed ID: 4865670
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies of the metabolism of fibrinogen-I 125 in cases of chronic glomerulonephritis and pyelonephritis and in uremic patients treated by periodical hemodialysis].
    Huber W; Previato G; Bertoli M; Cancarini GC; Toigo G; Gasparotto ML; Romagnoli GF
    G Clin Med; 1975; 56(11-12):431-44. PubMed ID: 1233337
    [No Abstract]   [Full Text] [Related]  

  • 14. Coagulation disorders in uremia.
    Molino D; De Lucia D; Gaspare De Santo N
    Semin Nephrol; 2006 Jan; 26(1):46-51. PubMed ID: 16412826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global fibrinolytic capacity in children on dialysis.
    Agras PI; Baskin E; Cengiz N; Kirazli S; Saatci U; Ozbek N
    Thromb Res; 2005; 115(3):185-9. PubMed ID: 15617740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of hemoperfusion on various blood coagulation and fibrinolysis factors in chronic uremia].
    Lewicki R; Trznadel K; Luciak M; Kidawa Z
    Pol Tyg Lek; 1981 Aug; 36(35):1325-7. PubMed ID: 7329845
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of middle molecules in uremic patients.
    Wu ZG; Cai ZH; Lu ZN; Liao LT; Zhu SQ
    Chin Med J (Engl); 1985 Feb; 98(2):115-20. PubMed ID: 3922688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.